Results 261 to 270 of about 4,455,205 (312)
, 1920 Some of the next articles are maybe not open access.
Related searches:
Related searches:
Blood Reviews
Evans syndrome (ES) is a rare acquired autoimmune disease defined by the presence of at least two of the three autoimmune cytopenias: immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and autoimmune neutropenia. At an incidence of approximately 10 to 30 times lower than AIHA and ITP, respectively, ES has been historically overlooked ...
Debbie, Jiang, David J, Kuter
exaly +4 more sources
Evans syndrome (ES) is a rare acquired autoimmune disease defined by the presence of at least two of the three autoimmune cytopenias: immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and autoimmune neutropenia. At an incidence of approximately 10 to 30 times lower than AIHA and ITP, respectively, ES has been historically overlooked ...
Debbie, Jiang, David J, Kuter
exaly +4 more sources
Immunoregulatory abnormalities in evans syndrome
American Journal of Hematology, 1983AbstractImmune function in six patients with Evans syndrome (Coombs‐positive hemolytic anemia and immune thrombocytopenia) was compared to that in seven with chronic ITP. The two groups differed in measurements of T‐cell subsets and immunoglobulin production.
Winfred Wang, Ching-Hon Pui, C H Pui
exaly +3 more sources
British Journal of Haematology, 2023
Currently, there is no effective treatment for refractory/relapsed (R/R) autoimmune haemolytic anaemia (AIHA), associated with poor quality of life. Bruton tyrosine kinase inhibitors have begun to be used in some autoimmune diseases.
Hui Liu +8 more
semanticscholar +1 more source
Currently, there is no effective treatment for refractory/relapsed (R/R) autoimmune haemolytic anaemia (AIHA), associated with poor quality of life. Bruton tyrosine kinase inhibitors have begun to be used in some autoimmune diseases.
Hui Liu +8 more
semanticscholar +1 more source
British Journal of Haematology, 2005
SummaryEvans syndrome is an uncommon condition defined by the combination (either simultaneously or sequentially) of immune thrombocytopenia (ITP) and autoimmune haemolytic anaemia (AIHA) with a positive direct antiglobulin test (DAT) in the absence of known underlying aetiology.
Alice, Norton, Irene, Roberts
openaire +2 more sources
SummaryEvans syndrome is an uncommon condition defined by the combination (either simultaneously or sequentially) of immune thrombocytopenia (ITP) and autoimmune haemolytic anaemia (AIHA) with a positive direct antiglobulin test (DAT) in the absence of known underlying aetiology.
Alice, Norton, Irene, Roberts
openaire +2 more sources
The Journal of Pediatrics, 1980
The combination of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia is rare in childhood. Among 164 instances of ITP and 15 instances of AHA, 11 patients were found to have this combination. Three were found to have systemic lupus erythematosus, one had aplastic anemia, and seven had Evans syndrome.
C H, Pui, J, Wilimas, W, Wang
openaire +2 more sources
The combination of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia is rare in childhood. Among 164 instances of ITP and 15 instances of AHA, 11 patients were found to have this combination. Three were found to have systemic lupus erythematosus, one had aplastic anemia, and seven had Evans syndrome.
C H, Pui, J, Wilimas, W, Wang
openaire +2 more sources
Pseudohypoparathyroidism Ia With Evans Syndrome
Journal of Pediatric Hematology/Oncology, 2008Pseudohypoparathyroidism Ia (Albright hereditary osteodystrophy or Albright syndrome) is a rare disease, caused by the resistance to the action of the parathyroid hormone in target tissues, such as the bone, kidney, and intestine, with consequent hypocalcemia and hyperphosphatemia and increased levels of parathyroid hormone.
PAVONE P +3 more
openaire +5 more sources
Diagnosis and management of Evans syndrome in adults: first consensus recommendations.
The Lancet HaematologyEvans syndrome is a rare disease marked by a severe clinical course, high relapse rate, infectious and thrombotic complications, and sometimes fatal outcome. Management is highly heterogeneous.
B. Fattizzo +15 more
semanticscholar +1 more source